Jacob Newman Marcus
Affiliation: Merck Research Laboratories
- Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's diseaseJacob Newman Marcus
Department of Neurosymptomatics, Merck Research Laboratories, West Point, PA 19486, USA
J Neurogenet 25:127-33. 2011..This review will discuss several post-translational modifications of tau and their roles in modulation of tau function and aggregation in AD...